RYCCX
Price
$515.44
Change
+$2.12 (+0.41%)
Updated
Dec 3 closing price
Net Assets
1.58B
ULPIX
Price
$169.33
Change
+$0.77 (+0.46%)
Updated
Dec 2 closing price
Net Assets
207.82M
Interact to see
Advertisement

RYCCX vs ULPIX

Header iconRYCCX vs ULPIX Comparison
Open Charts RYCCX vs ULPIXBanner chart's image
Rydex NASDAQ-100® 2x Strategy C
Price$515.44
Change+$2.12 (+0.41%)
VolumeN/A
Net Assets1.58B
ProFunds UltraBull I
Price$169.33
Change+$0.77 (+0.46%)
VolumeN/A
Net Assets207.82M
RYCCX vs ULPIX Comparison Chart in %
View a ticker or compare two or three
VS
RYCCX vs. ULPIX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYCCX is a Buy and ULPIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYCCX has more cash in the bank: 1.58B vs. ULPIX (208M). ULPIX pays higher dividends than RYCCX: ULPIX (0.75) vs RYCCX (0.00). RYCCX was incepted earlier than ULPIX: RYCCX (25 years) vs ULPIX (28 years). RYCCX (2.62) is less costly to investors than ULPIX (1.53). RYCCX is a more actively managed with annual turnover of: 383.00 vs. ULPIX (217.00). RYCCX has a lower initial minimum investment than ULPIX: RYCCX (2500) vs ULPIX (15000). RYCCX annual gain was more profitable for investors over the last year : 18.44 vs. ULPIX (15.21). ULPIX (94.04) and RYCCX (91.41) have equivalent 5 years return.
RYCCXULPIXRYCCX / ULPIX
Total Expense Ratio2.501.53163%
Annual Report Gross Expense Ratio2.621.53171%
Fund Existence25 years28 years-
Gain YTD30.46525.305120%
Front LoadN/AN/A-
Min. Initial Investment25001500017%
Min. Initial Investment IRAN/AN/A-
Net Assets1.58B208M762%
Annual Yield % from dividends0.000.75-
Returns for 1 year18.4415.21121%
Returns for 3 years201.44103.14195%
Returns for 5 years91.4194.0497%
Returns for 10 years594.88396.37150%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSFBX32.39N/A
N/A
Morgan Stanley Inst Global Franchise A
UMEMX16.84N/A
N/A
Columbia Emerging Markets Inst
GSAEX28.22N/A
N/A
Goldman Sachs China Equity Inv
JHUJX39.19N/A
N/A
JPMorgan Emerging Markets Equity R2
FSSJX13.94N/A
N/A
Fidelity Series Select Intl Sm Cp